Literature DB >> 8760193

Economy of contraction of cardiomyocytes as influenced by different positive inotropic interventions.

S Pöpping1, S Mruck, Y Fischer, D Kulsch, I Ionescu, H Kammermeier, H Rose.   

Abstract

In the present study the effects of the novel cardiotonic agent EMD-57033 on contraction and energetic demand of isolated, electrically stimulated cardiomyocytes were investigated and compared with the effects of enhancement of extracellular calcium and of the beta-mimetic isoproterenol. In a specially designed setup [H. Rose, K.H. Strotmann, S. Pöpping, Y. Fischer, D. Kulsch, and H. Kammermeier. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1329-H1334, 1991] parameters of contractile behavior and metabolic demand (O2 consumption) of isolated cardiac myocytes were measured. For a given enhancement of contractile performance (cell shortening) the increase in energetic demand (VO2) after application of EMD-57033 were markedly lower than on treatment with elevated extracellular Ca2+ concentration or with isoproterenol. This economization of positive inotropic effects was proposed to be due to two factors. First, stimulation-related ion cycling was only slightly enhanced with marked increase in contraction amplitude after application of EMD-57033. Second, calcium sensitization reflected in a leftward shift of the calcium concentration needed for half-maximum force development could be interpreted to be mediated by modulation of the cross-bridge dynamics of the myofilaments, where reduction of the switch-off rate of the cross bridges and prolongation of their force-generating states were presumed to be involved. Lowered pH (7.0) decreased economy of contraction. EMD-57033 restored contraction amplitude and economy of contraction at lowered pH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760193     DOI: 10.1152/ajpheart.1996.271.1.H357

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Kir6.2 is required for adaptation to stress.

Authors:  Leonid V Zingman; Denice M Hodgson; Peter H Bast; Garvan C Kane; Carmen Perez-Terzic; Richard J Gumina; Darko Pucar; Martin Bienengraeber; Petras P Dzeja; Takashi Miki; Susumu Seino; Alexey E Alekseev; Andre Terzic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

2.  SR33805, a Ca2+ antagonist with length-dependent Ca2+ -sensitizing properties in cardiac myocytes.

Authors:  Olivier Cazorla; Alain Lacampagne; Jeremy Fauconnier; Guy Vassort
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  High calcium and dobutamine positive inotropy in the perfused mouse heart: myofilament calcium responsiveness, energetic economy, and effects of protein kinase C inhibition.

Authors:  G A MacGowan; C Du; A P Koretsky
Journal:  BMC Physiol       Date:  2001-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.